https://www.zawya.com/en/press-release/companies-news/daewoong-pharmaceutical-a-leading-healthcare-company-in-korea-has-launched-its-botulinum-toxin-product-nabota-in-saudi-arabia-pnx2pcs6
The launch follows a rigorous quality evaluation process conducted by the Saudi Food and Drug Authority
daewoong pharmaceuticalin korealeadinghealthcarecompany
https://pubmed.ncbi.nlm.nih.gov/21291464/?dopt=Abstract
The use of BoNT-A with usual care or physiotherapy seems to improve walking of children with CP, but results should be appraised carefully owing to the limited...
botulinum toxin aleg muscleeffectsinjectionswalking
https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2023.1245228/full
Background: Current guidelines recommend intramuscular botulinum toxin type A (BoNT-A) injection as first-line treatment for spasticity, a frequent and impai...
botulinum toxinfrontiersusepatientspost